Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paired, randomized, double-blind, placebo-controlled trial of EMLA cream for primary localized cutaneous amyloidosis
TCTR20170928005Phase 3Not yet recruiting
- Start
- Oct 2017
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine + prilocaine in primary cutaneous amyloidosis (PCA), sponsored by none. Planned start Oct 2017; status: not yet recruiting.
02
Drugs
lidocaine + prilocaine
03
Conditions
primary cutaneous amyloidosis (PCA)
Beyond the preview
Go deeper on TCTR20170928005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170928005.